ArticleFrontiers in pharmacology2022

Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD.

Haichuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.